SCHEMBL4665662

SCHEMBL4665662

CCc1cc(N)n(-c2ncccc2C)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOS3 P29474 2/20 0.40
▸ NOS2 P35228 2/20 0.40
▸ NOS1 P29475 1/20 0.40
▸ ADRA2A P08913 1/20 0.36
▸ ADRA2B P18089 1/20 0.36
▸ ADRA2C P18825 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.35
▸ HRH3 Q9Y5N1 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ MAPT P10636 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ PKM P14618 1/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ OPRL1 P41146 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ NFKB1 P19838 1/20 0.33
▸ RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25008755 0.78 KDM5A (0.42) NPSR1MAPTALDH1A1NPC1RAB9A
SCHEMBL4668551 0.77 SMN1; SMN2 (0.46) HRH3CYP1A2CYP2C19MAPTALDH1A1
SCHEMBL4666100 0.76 MAPT (0.47) NPSR1MAPTALDH1A1L3MBTL1KDM4E
SCHEMBL25008712 0.75 ALDH1A1 (0.48) CYP1A2MAPK1CYP2C19MAPTALDH1A1
SCHEMBL4666587 0.74 NPC1 (0.49) NOS3NOS2NOS1HRH3MAPT
SCHEMBL15210050 0.72 SLC9A1 (0.43) MAPTKDM4EP2RX7
SCHEMBL2029110 0.72 ALDH1A1 (0.47) CYP1A2CYP2C19MAPTALDH1A1KDM4E
SCHEMBL4665764 0.72 NOS3 (0.34) NOS3NOS2NOS1HRH3CYP1A2
SCHEMBL1013253 0.71 CYP1A2 (0.61) CYP1A2MAPK1CYP2C19MAPTALDH1A1
SCHEMBL4665822 0.71 CA12 (0.46) NOS3NOS2CYP1A2MAPK1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1928455-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES Bayer Healthcare, LLC (US) 2008-06-11 — — EP disclosed
WO-2007027842-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER HEALTHCARE LLC (US) 2007-03-08 — — WO disclosed
Send feedback